Literature DB >> 17333204

Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.

O Karagülle1, U Smorag, F Candir, G Gundermann, U Jonas, A J Becker, A Gehrke, C Gutenbrunner.   

Abstract

Investigations in healthy persons have shown that drinking mineral water containing HCO(3) has a positive effect on urine supersaturated with calcium oxalate (SS(CaOx)). The present study evaluates in a common setting whether these effects are also relevant in patients with multiepisodic urinary stone formation. A total of 34 patients with evident multiepisodic CaOx-urolithiasis were included in the study. Patients with hyperparathyroidism, renal tubular acidosis, Wilson's disease, Cushing disease, osteoporosis and malignant diseases were excluded. In a cross-over design and double-blinded the patients received 1.5 l of a mineral water with 2.673 mg HCO(3)/l (test water) or the same amount of water with a low mineral content (98 mg HCO(3)/l) (control water) daily for 3 days. During the study period the patients diet was recorded in a protocol, but not standardised. The main target parameter was SS(CaOx )in 24 h urine. In addition, urinary pH and the most important inhibiting and promoting factors were measured in 24 h urine (Ca, Ox, Mg, Cit). Both waters tested led to a highly significant increase in 24 h urine volume without a difference between each other. In the group, drinking the water containing HCO(3) the urinary pH increased significantly and was within a range relevant for metaphylaxis of calcium oxalate stone formation (x=6.73). This change was highly significant compared to the control group. In addition, significantly increased magnesium and citrate concentration were also observed. Supersaturation with calcium oxalate decreased significantly and to a relevant extent; however, there was no difference between the waters tested. As expected, the risk of uric acid precipitation also decreased significantly under bicarbonate water intake. However, an increase of the risk of calcium phosphate stone formation was observed. It is evident that both waters tested are able to lower significantly and to a relevant extent the risk of urinary stone formation in patients with multiepisodic CaOx-urolithiasis. In addition, the bicarbonate water increases the inhibitory factors citrate and magnesium due to its content of HCO(3) and Mg. Thus, it can be recommended for metaphylaxis of calcium oxalate and uric acid urinary stones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17333204     DOI: 10.1007/s00345-007-0144-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  20 in total

1.  Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects.

Authors:  T Kessler; A Hesse
Journal:  Br J Nutr       Date:  2000-12       Impact factor: 3.718

2.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

3.  Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis.

Authors:  R Caudarella; E Rizzoli; A Buffa; A Bottura; S Stefoni
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

Review 4.  Risk formulas in calcium oxalate urolithiasis.

Authors:  H G Tiselius
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  EQUIL2: a BASIC computer program for the calculation of urinary saturation.

Authors:  P G Werness; C M Brown; L H Smith; B Finlayson
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

6.  [Purine loading test in calcium-oxalate stone formers (author's transl)].

Authors:  B Lux; J Braun; P May
Journal:  Urologe A       Date:  1982-05       Impact factor: 0.639

7.  Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors.

Authors:  A L Rodgers
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

8.  Magnesium absorption from mineral waters of different magnesium content in healthy subjects.

Authors:  Oguz Karagülle; Thomas Kleczka; Christian Vidal; Fatma Candir; Gisela Gundermann; Wolf Rüdiger Külpmann; Axel Gehrke; Christoph Gutenbrunner
Journal:  Forsch Komplementmed       Date:  2006-01-03

9.  Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.

Authors:  K Sakhaee; M Nicar; K Hill; C Y Pak
Journal:  Kidney Int       Date:  1983-09       Impact factor: 10.612

Review 10.  A complementary approach to urolithiasis prevention.

Authors:  Robert A Anderson
Journal:  World J Urol       Date:  2002-10-17       Impact factor: 4.226

View more
  14 in total

Review 1.  A proposal for a worldwide definition of health resort medicine, balneology, medical hydrology and climatology.

Authors:  Christoph Gutenbrunner; Tamas Bender; Pedro Cantista; Zeki Karagülle
Journal:  Int J Biometeorol       Date:  2010-06-09       Impact factor: 3.787

Review 2.  Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?

Authors:  Roswitha Siener
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

3.  Physicochemical fingerprinting of thermal waters of Beira Interior region of Portugal.

Authors:  A R T S Araujo; M C Sarraguça; M P Ribeiro; P Coutinho
Journal:  Environ Geochem Health       Date:  2016-05-03       Impact factor: 4.609

Review 4.  Dietary therapy for patients with hypocitraturic nephrolithiasis.

Authors:  Michael P Kurtz; Brian H Eisner
Journal:  Nat Rev Urol       Date:  2011-02-15       Impact factor: 14.432

5.  The effects of drinking bicarbonate-rich mineral water in calcium oxalate stone formers: an open label prospective randomized controlled study in an Asian cohort.

Authors:  Yadong Lu; Palaniappan Sundaram; HuiHua Li; Tsung Wen Chong
Journal:  Int Urol Nephrol       Date:  2022-07-04       Impact factor: 2.266

Review 6.  Treatment of patients with uric acid stones.

Authors:  Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

7.  Effect of water composition and timing of ingestion on urinary lithogenic profile in healthy volunteers: a randomized crossover trial.

Authors:  Pietro Manuel Ferraro; Rocco Baccaro; Silvia Baroni; Ludovica D'Alessandri; Claudio Carpenito; Nicola Di Daniele; Andrea Urbani; Giovanni Gambaro
Journal:  J Nephrol       Date:  2020-06-08       Impact factor: 3.902

Review 8.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

9.  Global Variations in the Mineral Content of Bottled Still and Sparkling Water and a Description of the Possible Impact on Nephrological and Urological Diseases.

Authors:  Simone J M Stoots; Guido M Kamphuis; Rob Geraghty; Liffert Vogt; Michaël M E L Henderickx; B M Zeeshan Hameed; Sufyan Ibrahim; Amelia Pietropaolo; Enakshee Jamnadass; Sahar M Aljumaiah; Saeed B Hamri; Eugenio Ventimiglia; Olivier Traxer; Vineet Gauhar; Etienne X Keller; Vincent De Coninck; Otas Durutovic; Nariman K Gadzhiev; Laurian B Dragos; Tarik Emre Sener; Nick Rukin; Michele Talso; Panagiotis Kallidonis; Esteban Emiliani; Ewa Bres-Niewada; Kymora B Scotland; Naeem Bhojani; Athanasios Vagionis; Angela Piccirilli; Bhaskar K Somani
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

Review 10.  Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.

Authors:  Giovanni Gambaro; Emanuele Croppi; Fredric Coe; James Lingeman; Orson Moe; Elen Worcester; Noor Buchholz; David Bushinsky; Gary C Curhan; Pietro Manuel Ferraro; Daniel Fuster; David S Goldfarb; Ita Pfeferman Heilberg; Bernard Hess; John Lieske; Martino Marangella; Dawn Milliner; Glen M Preminger; Jose' Manuel Reis Santos; Khashayar Sakhaee; Kemal Sarica; Roswitha Siener; Pasquale Strazzullo; James C Williams
Journal:  J Nephrol       Date:  2016-07-25       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.